Physiological-immune resilience risk assessment model for predicting adverse cardiac outcomes in patients with acute myocardial infarction

Patients with AMI undergoing percutaneous coronary intervention (PCI) remain at risk of adverse cardiac outcomes, which may be associated with the physiological resilience score, hs-CRP, SII, and SIRI. These indicators demonstrate substantial predictive value for 30-day MACE in AMI patients. Accordingly, early clinical interventions targeting these risk factors are recommended to reduce the incidence of adverse cardiac outcomes and improve patient prognosis.